One-year mortality was increased in the non-Aspergillus group (39.5% vs. 60.5%, P = 0.03).There is significant overlap in risk factors, presentation, and radiographic patterns in IMI in LT or HLT recipients.
Moreover, in patients who bled, hospital mortality was increased in those who discontinued aspirin, thienopyridines, or low-molecular-weight heparins.
The mortality was increased up to 96.6, 93.3, and 90.0% in the third day of exposure.
RESULTS: Post-operative day 7 mortality was increased in the HSHI group (7/11) compared to the HI (0/9) group, P = 0.038.
After that, the mortality was increased up to 100% in the 11th day of treatment (Fig. 3a).
Hence, mortality was increased with the use of hydroxyethylstarches (HES) [21] or by L-NAME administration [16].
All models showed that mortality was increased by older age, female sex, firearm mechanism, and injuries involving the head/neck or trunk.
Conclusions: Short-term and 6-month mortality was increased significantly with higher fasting glucose levels in patients across the spectrum of acute coronary syndromes, thus extending this relation to patients with non-ST-segment elevation myocardial infarction.
Even though the overall mortality was increased across both time periods, it did not reach statistical significance for the period 1989 2003.
Mortality was increased in patients poorly responsive to ESAs (55.5%).
In addition, mortality was increased in the intervention group at 12 months.
